Skip to main navigation

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

Quarterly Results

Show all

2025

Q1

Y-mAbs Reports First Quarter 2025 Financial Results and Recent Corporate Developments
First Quarter 2025 Financial and Operating Results Presentation 892.6 KB
Form 10-Q

2024

Q4

Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments
Q4 & FY 2024 Financial Results and Corporate Presentation 1.4 MB
Form 10-K

Q3

Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
Third Quarter 2024 Financial and Operating Results Presentation 1.3 MB
Form 10-Q

Q2

Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
Second Quarter 2024 Financial and Operating Results Presentation 1.3 MB
Form 10-Q

Q1

Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
First Quarter 2024 Financial and Operating Results Presentation 981.1 KB
Form 10-Q

2023

Q4

Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
Q4 & FY 2023 Financial Results and Corporate Presentation 1 MB
Form 10-K

Q3

Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
Form 10-Q

Q2

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
Form 10-Q

Q1

Y-mAbs Reports First Quarter 2023 Financial Results and Recent Corporate Developments and Updates 2023 Financial Guidance
Form 10-Q

About us
Our Portfolio
DANYELZA®
Partnerships
Resources
Investors
Careers

Company

About Us
Leadership
Culture of Integrity
Community Guidelines
Careers
Contact

Science

Radiopharmaceuticals
Naxitamab
DANYELZA®
Partnerships
Scientific Resources

Support

ISS Grant Submission
Resources
Patients & Caregivers
Physicians

Investors

Overview
Stock Information
News & Presentations
Financial Information
Corporate Governance
Investor Resources

Accessibility
Cookie Policy
Privacy Statement
Terms of Use

Copyright © 2025 Y-mAbs Therapeutics, Inc. All rights reserved. CRP-000001 03/2024

Scroll to Top